US FDA's New Global Office Aims To Elevate and Enhance Agency’s Role On World Stage
Executive Summary
There is growing recognition that the US FDA can use trade agreements to help confront the challenges of globalization and that these agreements can play an increasingly important role in fostering regulatory alignment and improving the quality of imports, agency official says.
You may also be interested in...
Two More Member States Join US-EU Inspections Deal
The number of European countries whose drug manufacturing site inspections the US regulator can rely on in place of its own inspections has grown.
Program Participants Urge The FDA To Adopt Some Pharmaceutical Quality Metrics And Avoid Others
Site-based metrics praised; lot acceptance rates, invalidated OOS rates discouraged. Agency official admits some proposed metrics were “not the best.”